Menderes Yusuf Terzi
Research Subjects
Menderes Yusuf Terzi has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Aydıner Kalacı
Department of Orthopaedics and Traumatology, Faculty of Medicine, Mustafa Kemal University, Antakya, Hatay, Turkey
3 shared publications Hamza Malik Okuyan
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Sakarya University of Applied Sciences, Sakarya, Türkiye
3 shared publications- Hamza Malik Okuyan
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Physiotherapy and Rehabilitation Application and Research Center, Sakarya University of Applied Sciences, Sakarya, Turkey
3 shared publications - Ana Luisa Piña
Department of Neurosurgery, Experimental Neurosurgery/BCRT, Charite-Universitätsmedizin Berlin, Campus Mitte, Chariteplatz 1/Virchowweg 21, Aschheim-Zondek-Haus 03-003, 10117, Berlin, Germany.
2 shared publications - Arina Riabinska
Department of Neurosurgery, Experimental Neurosurgery/BCRT, Charite-Universitätsmedizin Berlin, Campus Mitte, Chariteplatz 1/Virchowweg 21, Aschheim-Zondek-Haus 03-003, 10117, Berlin, Germany
2 shared publications Aydıner Kalacı
Department of Orthopedics and Traumatology, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Turkey
2 shared publications
Latest Publications
- 21 March 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Enhanced neuroprotection against Alzheimer’s disease by combining Inula viscosa with curcumin: an in vitro study
Introduction: Alzheimer’s disease (AD), the most prevalent type of dementia among older individuals, is characterized by severe neurodegeneration with symptoms of progressive loss of cognitive capacity. We aimed to investigate the effects of curcumin (Curc) and Inula viscosa (IV) plant extracts on apoptosis and oxidative stress in an amyloid-β (Aβ)-induced in vitro AD model.Material and methods: The human glioblastoma cell line (U87) was treated with Aβ to produce an in vitro AD model. Treatment groups were: Aβ + Curc, Aβ + IV, and Aβ + IV + Curc. Cell viability assay was performed to analyze cytotoxicity. Caspase-3 (CASP3) levels were measured to evaluate apoptosis. For oxidative stress, glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD), total antioxidant (TAS), and total oxidant (TOS) levels were analyzed spectrophotometrically.Results: Combinatory application of IV and Curc post-Aβ treatment increased cell viability of U87 cells. Aβ-upregulated CASP3 levels were markedly reduced upon IV and Curc co-treatment. Anti-oxidant parameters, i.e., SOD, CAT, GPx, and TAS levels, were significantly elevated in the IV + Curc-treated group compared to the Aβ group. The elevated TOS level after Aβ exposure returned to its basal level upon Curc + IV co-treatment.Conclusions: IV + Curc co-treatment reduced apoptosis-related neurodegeneration and supported antioxidant activity in an Aβ-induced AD model of U87 cells. IV and Curc co-treatment can be a promising therapeutic strategy against AD.
- 21 March 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Enhanced neuroprotection against Alzheimer’s disease by combining Inula viscosa with curcumin: an in vitro study
Introduction: Alzheimer’s disease (AD), the most prevalent type of dementia among older individuals, is characterized by severe neurodegeneration with symptoms of progressive loss of cognitive capacity. We aimed to investigate the effects of curcumin (Curc) and Inula viscosa (IV) plant extracts on apoptosis and oxidative stress in an amyloid-β (Aβ)-induced in vitro AD model.Material and methods: The human glioblastoma cell line (U87) was treated with Aβ to produce an in vitro AD model. Treatment groups were: Aβ + Curc, Aβ + IV, and Aβ + IV + Curc. Cell viability assay was performed to analyze cytotoxicity. Caspase-3 (CASP3) levels were measured to evaluate apoptosis. For oxidative stress, glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD), total antioxidant (TAS), and total oxidant (TOS) levels were analyzed spectrophotometrically.Results: Combinatory application of IV and Curc post-Aβ treatment increased cell viability of U87 cells. Aβ-upregulated CASP3 levels were markedly reduced upon IV and Curc co-treatment. Anti-oxidant parameters, i.e., SOD, CAT, GPx, and TAS levels, were significantly elevated in the IV + Curc-treated group compared to the Aβ group. The elevated TOS level after Aβ exposure returned to its basal level upon Curc + IV co-treatment.Conclusions: IV + Curc co-treatment reduced apoptosis-related neurodegeneration and supported antioxidant activity in an Aβ-induced AD model of U87 cells. IV and Curc co-treatment can be a promising therapeutic strategy against AD.
- Open Access
- 11 February 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (4) , 1691-1704
miR-451a and IL18 can differentiate familial Mediterranean fever patients in attack and remission periods: a prospective cross-sectional study
Objectives: Familial Mediterranean fever (FMF) is a multifaceted autoimmune disease and requires a diligent strategical approach considering disease periods and mutation subtypes. We aimed to investigate serum levels of autoimmunity-related cell-free miRNAs and inflammatory and apoptotic markers in FMF patients. Methods: Sixty FMF patients, of which 30 were in attack (FMF-A) and 30 were in remission (FMF-R) periods, and 25 age-, sex-, and BMI-matched healthy controls were included in our study. The expression levels of miR-26a-5p, miR-146a-5p, miR-155–2-5p, and miR-451a were analyzed with reverse-transcriptase quantitative polymerase chain reaction, and protein levels of interleukin-18 (IL18) and soluble Fas cell surface death receptor (sFAS) were measured with enzyme-linked immunosorbent assay. Serum CRP levels were analyzed by nephelometry, ferritin levels by chemiluminescence, and routine biochemical parameters by spectrophotometry. Correlation analyses were performed to seek potential associations of miRNAs with serum markers and biochemical parameters. Potential biomarkers were tested with receiver operating characteristic analysis. Results: We observed elevated serum IL18 levels but not sFAS, in FMF patients, particularly during attack period. IL18 demonstrated diagnostic value and was significantly correlated with acute-phase markers namely CRP, fibrinogen, and ferritin. Altered levels of IL18 and miR-451a could distinguish FMF patients in the attack period from the ones in remission. miR-26a-5p, miR-146a-5p, and miR-155–2-5p were downregulated in FMF patients carrying M694V mutations. Conclusions: These findings suggest that IL18 and specific miRNAs can serve as potential biomarkers for FMF pathogenesis. Discovering promising targets for FMF-related miRNAs using mechanistic strategies will enhance our understanding of FMF disease management and therapy. Key Points • miR-451a and IL18 can serve as an indicator in distinguishing familial Mediterranean fever patients in attack and remission periods.• miR-26a-5p, miR-146a-5p, and miR-155–2-5p were dysregulated in FMF patients carrying M694V mutation.
- 11 February 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 44 (4) , 1691-1704
Open AccessmiR-451a and IL18 can differentiate familial Mediterranean fever patients in attack and remission periods: a prospective cross-sectional study
Objectives: Familial Mediterranean fever (FMF) is a multifaceted autoimmune disease and requires a diligent strategical approach considering disease periods and mutation subtypes. We aimed to investigate serum levels of autoimmunity-related cell-free miRNAs and inflammatory and apoptotic markers in FMF patients. Methods: Sixty FMF patients, of which 30 were in attack (FMF-A) and 30 were in remission (FMF-R) periods, and 25 age-, sex-, and BMI-matched healthy controls were included in our study. The expression levels of miR-26a-5p, miR-146a-5p, miR-155–2-5p, and miR-451a were analyzed with reverse-transcriptase quantitative polymerase chain reaction, and protein levels of interleukin-18 (IL18) and soluble Fas cell surface death receptor (sFAS) were measured with enzyme-linked immunosorbent assay. Serum CRP levels were analyzed by nephelometry, ferritin levels by chemiluminescence, and routine biochemical parameters by spectrophotometry. Correlation analyses were performed to seek potential associations of miRNAs with serum markers and biochemical parameters. Potential biomarkers were tested with receiver operating characteristic analysis. Results: We observed elevated serum IL18 levels but not sFAS, in FMF patients, particularly during attack period. IL18 demonstrated diagnostic value and was significantly correlated with acute-phase markers namely CRP, fibrinogen, and ferritin. Altered levels of IL18 and miR-451a could distinguish FMF patients in the attack period from the ones in remission. miR-26a-5p, miR-146a-5p, and miR-155–2-5p were downregulated in FMF patients carrying M694V mutations. Conclusions: These findings suggest that IL18 and specific miRNAs can serve as potential biomarkers for FMF pathogenesis. Discovering promising targets for FMF-related miRNAs using mechanistic strategies will enhance our understanding of FMF disease management and therapy. Key Points • miR-451a and IL18 can serve as an indicator in distinguishing familial Mediterranean fever patients in attack and remission periods.• miR-26a-5p, miR-146a-5p, and miR-155–2-5p were dysregulated in FMF patients carrying M694V mutation.
- 8 November 2024
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
The Identification of Methylation Profiles of FTO and PPARG Genes in Type 2 Diabetes Mellitus Patients
Type 2 diabetes (T2DM) is a complex, metabolic disease driven by genetic susceptibilities, environmental interactions, and various genes. Nowadays, increasing number of studies show the relationship between diabetes mellitus (DM) and epigenetics, especially DNA methylation. In this study, we aimed to measure the methylation levels of fat mass and obesity associated (FTO) and peroxisome proliferator activated receptor gamma (PPARG) in the peripheral blood samples of patients with clinical diagnosis of T2DM. In our study, whole blood was taken from T2DM patients (n=43) who applied to the Endocrinology Outpatient Clinic and from age-gender-matched healthy individuals (n=42). After the bisulfide conversion of isolated genomic DNAs from whole blood samples, the methylation profiles of target genes were analyzed with methyl-specific PCR and gel electrophoresis methods. Post-statistical analyses, no significant difference was found between the T2DM and control groups regarding FTO methylation status. The methylation level of PPARG gene in T2DM was significantly higher compared to the control group. Given the insulin sensitizing effects of PPARG, our findings confirm the possibility that methylation-mediated suppression of PPARG gene expression may lead to elevation of insulin resistance in T2DM patients. Further gene expression studies with more patients and quantitative methods will be required to better understand the effects of methylation in the PPARG gene in T2DM patients and its relationship to the disease.
- 8 November 2024
- Published by Mugla Sitki Kocman University in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
The Identification of Methylation Profiles of FTO and PPARG Genes in Type 2 Diabetes Mellitus Patients
Type 2 diabetes (T2DM) is a complex, metabolic disease driven by genetic susceptibilities, environmental interactions, and various genes. Nowadays, increasing number of studies show the relationship between diabetes mellitus (DM) and epigenetics, especially DNA methylation. In this study, we aimed to measure the methylation levels of fat mass and obesity associated (FTO) and peroxisome proliferator activated receptor gamma (PPARG) in the peripheral blood samples of patients with clinical diagnosis of T2DM. In our study, whole blood was taken from T2DM patients (n=43) who applied to the Endocrinology Outpatient Clinic and from age-gender-matched healthy individuals (n=42). After the bisulfide conversion of isolated genomic DNAs from whole blood samples, the methylation profiles of target genes were analyzed with methyl-specific PCR and gel electrophoresis methods. Post-statistical analyses, no significant difference was found between the T2DM and control groups regarding FTO methylation status. The methylation level of PPARG gene in T2DM was significantly higher compared to the control group. Given the insulin sensitizing effects of PPARG, our findings confirm the possibility that methylation-mediated suppression of PPARG gene expression may lead to elevation of insulin resistance in T2DM patients. Further gene expression studies with more patients and quantitative methods will be required to better understand the effects of methylation in the PPARG gene in T2DM patients and its relationship to the disease.
- Open Access
- 9 April 2024
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 30 (3) , 1-2
Correction: Urotensin-II Prevents Cartilage Degeneration in a Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis
- 9 April 2024
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 30 (3) , 1-2
Open AccessCorrection: Urotensin-II Prevents Cartilage Degeneration in a Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis
- Open Access
- 1 January 2024
- Published by Kare Publishing in Journal of Clinical Practice and Research
- Vol. 45 (6) , 614-623
Propranolol Treatment Reduces A549-Derived Lung Cancer Spheroids via Intrinsic Apoptosis
Propranolol (PRO), a non-selective beta-adrenergic receptor inhibitor, has been recently discovered to possess anti-tumorigenic effects in cancer patients. Therefore, we aimed to investigate the in vitro effects of PRO in A549-derived lung cancer spheroids in terms of cell viability, spheroid formation, cell cycle regulation, cell differentiation, and apoptosis. The effect of 24-hour PRO treatment on A549 cell viability was assessed using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. A sub-cytotoxic PRO concentration (125 μM) was employed to evaluate its impact on the clonogenicity of A549-derived cancer spheroids after seven days of incubation. Messenger Ribonucleic Acid (mRNA) levels of cell cycle regulators including cyclin-dependent kinase inhibitor 1A (p21) and G2 checkpoint kinase (WEE1), apoptotic markers such as caspases 3, 8, 9 (CASP3, CASP8, CASP9), and stem cell differentiation markers, namely POU class 5 homeobox 1 (octamer-binding transcription factor 4 (OCT4)), prominin 1 (CD133), and adenosine triphosphate (ATP) binding cassette subfamily G member 2 (ABCG2) were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR) after a 24-hour treatment of cancer spheroids with PRO. PRO treatment reduced cell viability and inhibited the clonogenicity of cancer spheroids by activating intrinsic apoptotic markers CASP3 and CASP9, leading to cell cycle arrest via increased p21 expression. PRO did not significantly alter stem cell differentiation markers. The proliferation and clonogenic activity of lung cancer spheroids can be effectively suppressed with PRO, primarily through inducing intrinsic apoptosis following p21-mediated cell cycle arrest. While short-term PRO exposure did not affect the gene expression levels of stem cell differentiation markers, the notable decrease in both cell viability and spheroid formation efficiency suggests the potential of PRO as a therapeutic drug in lung cancer treatment.
- 1 January 2024
- Published by Kare Publishing in Journal of Clinical Practice and Research
- Vol. 45 (6) , 614-623
Open AccessPropranolol Treatment Reduces A549-Derived Lung Cancer Spheroids via Intrinsic Apoptosis
Propranolol (PRO), a non-selective beta-adrenergic receptor inhibitor, has been recently discovered to possess anti-tumorigenic effects in cancer patients. Therefore, we aimed to investigate the in vitro effects of PRO in A549-derived lung cancer spheroids in terms of cell viability, spheroid formation, cell cycle regulation, cell differentiation, and apoptosis. The effect of 24-hour PRO treatment on A549 cell viability was assessed using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. A sub-cytotoxic PRO concentration (125 μM) was employed to evaluate its impact on the clonogenicity of A549-derived cancer spheroids after seven days of incubation. Messenger Ribonucleic Acid (mRNA) levels of cell cycle regulators including cyclin-dependent kinase inhibitor 1A (p21) and G2 checkpoint kinase (WEE1), apoptotic markers such as caspases 3, 8, 9 (CASP3, CASP8, CASP9), and stem cell differentiation markers, namely POU class 5 homeobox 1 (octamer-binding transcription factor 4 (OCT4)), prominin 1 (CD133), and adenosine triphosphate (ATP) binding cassette subfamily G member 2 (ABCG2) were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR) after a 24-hour treatment of cancer spheroids with PRO. PRO treatment reduced cell viability and inhibited the clonogenicity of cancer spheroids by activating intrinsic apoptotic markers CASP3 and CASP9, leading to cell cycle arrest via increased p21 expression. PRO did not significantly alter stem cell differentiation markers. The proliferation and clonogenic activity of lung cancer spheroids can be effectively suppressed with PRO, primarily through inducing intrinsic apoptosis following p21-mediated cell cycle arrest. While short-term PRO exposure did not affect the gene expression levels of stem cell differentiation markers, the notable decrease in both cell viability and spheroid formation efficiency suggests the potential of PRO as a therapeutic drug in lung cancer treatment.
- 4 May 2023
- Published by Taylor & Francis in Journal of Essential Oil Bearing Plants
- Vol. 26 (3) , 626-638
Myrtus communis L. essential oil reduced colony formation and altered cell differentiation markers in lung cancer spheroids
- 4 May 2023
- Published by Taylor & Francis in Journal of Essential Oil Bearing Plants
- Vol. 26 (3) , 626-638
Myrtus communis L. essential oil reduced colony formation and altered cell differentiation markers in lung cancer spheroids
- 9 August 2022
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 28 (5) , 1-13
Urotensin-II Prevents Cartilage Degeneration in a Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis
- 9 August 2022
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 28 (5) , 1-13
Urotensin-II Prevents Cartilage Degeneration in a Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis
- 19 April 2022
- Published by Allerton Press in Cytology and Genetics
- Vol. 56 (2) , 172-178
Reduced Expression of PEDF and ALDH1A1 during Spheroid Transition of Lung Cancer Cells: An In Vitro Study
“Cancer stem cells” (CSCs) can initiate tumorigenesis and metastasis and show resistance against chemotherapy owing to the expression of promin
- 19 April 2022
- Published by Allerton Press in Cytology and Genetics
- Vol. 56 (2) , 172-178
Reduced Expression of PEDF and ALDH1A1 during Spheroid Transition of Lung Cancer Cells: An In Vitro Study
“Cancer stem cells” (CSCs) can initiate tumorigenesis and metastasis and show resistance against chemotherapy owing to the expression of promin
- 1 January 2022
- Published by Allerton Press in Cytology and Genetics
- Vol. 56 (1) , 66-76
Effect of Glucose Starvation on Cell Viability Parameters in A549 and BEAS-2B Cell Lines
Cancer cells are metabolically altered cells characterized by higher glucose uptake. Understanding cancer cells is vital in cancer therapy. We aimed to ana
- 1 January 2022
- Published by Allerton Press in Cytology and Genetics
- Vol. 56 (1) , 66-76
Effect of Glucose Starvation on Cell Viability Parameters in A549 and BEAS-2B Cell Lines
Cancer cells are metabolically altered cells characterized by higher glucose uptake. Understanding cancer cells is vital in cancer therapy. We aimed to ana
- 25 March 2021
- Published by Inonu University in İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi
- Vol. 9 (1) , 353-361
UROTENSİN II’NİN İNSAN OSTEOBLAST HÜCRELERİNDE ENFLAMASYONLA İLİŞKİLİ ROLÜ
Osteoartrit (OA), kemik, kıkırdak ve sinoviyal dokuda katabolik değişikliklere neden olan yaygın bir eklem hastalığıdır. OA’nın güncel tedavisi, hastalığı tamamen iyileştirmek için yeterli değildir. Eklem kondrositlerinin yanı sıra, kemik hücrelerindeki OA ile ilişkili mekanizmaların anlaşılması bu hastalığın önlenmesi ve tedavisine katkı sağlayacaktır. Urotensin II (UTS2), nörohormon benzeri aktiviteye sahip polipeptid bir moleküldür ve kardiyovasküler, pulmoner, renal ve merkezi sinir sisteminde eksprese edildiği bilinmektedir. Pek çok sistem üzerinde patofizyolojik etkileri olan UTS2’nin, OA’daki moleküler mekanizması tam olarak bilinmemektedir. Bu çalışmada, insan osteoblast hücreleri kullanılarak UTS2’nin OA patogenezindeki enflamasyonla ve apoptozis ile ilişkili rolünün incelenmesi amaçlanmıştır. Bu çalışmada, insan osteoblast hücreleri, tümör nekroz faktörü alfa (TNF-α) ve UTS2’ye maruz bırakıldı. İnkübasyon süresinin sonunda hücrelerden RNA izole edildi ve kantitatif ters transkripsiyon-polimeraz zincir reaksiyonu analizleri yapıldı. TNF-α maruziyeti, interlökin 6 ve nükleer faktör kappa B gen ekspresyon seviyelerinde anlamlı düzeyde bir artışa neden olmuştur. UTS2 maruziyeti, kendi gen ekspresyon seviyesini azaltmıştır. TNF-a ve UTS2 maruziyetleri, Kaspaz-3 gen ekspresyonu üzerinde istatistiksel olarak anlamlı bir farklılığa neden olmamıştır. Çalışmamızda, bulgularımız; insan osteoblast hücrelerinde UTS2’nin eksprese edildiğini ve UTS2’nin hücre kültür ortamına eklenmesi bu genin kendi ekspresyon seviyeleri üzerinde etkili olabileceğini göstermektedir.
- 25 March 2021
- Published by Inonu University in İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi
- Vol. 9 (1) , 353-361
UROTENSİN II’NİN İNSAN OSTEOBLAST HÜCRELERİNDE ENFLAMASYONLA İLİŞKİLİ ROLÜ
Osteoartrit (OA), kemik, kıkırdak ve sinoviyal dokuda katabolik değişikliklere neden olan yaygın bir eklem hastalığıdır. OA’nın güncel tedavisi, hastalığı tamamen iyileştirmek için yeterli değildir. Eklem kondrositlerinin yanı sıra, kemik hücrelerindeki OA ile ilişkili mekanizmaların anlaşılması bu hastalığın önlenmesi ve tedavisine katkı sağlayacaktır. Urotensin II (UTS2), nörohormon benzeri aktiviteye sahip polipeptid bir moleküldür ve kardiyovasküler, pulmoner, renal ve merkezi sinir sisteminde eksprese edildiği bilinmektedir. Pek çok sistem üzerinde patofizyolojik etkileri olan UTS2’nin, OA’daki moleküler mekanizması tam olarak bilinmemektedir. Bu çalışmada, insan osteoblast hücreleri kullanılarak UTS2’nin OA patogenezindeki enflamasyonla ve apoptozis ile ilişkili rolünün incelenmesi amaçlanmıştır. Bu çalışmada, insan osteoblast hücreleri, tümör nekroz faktörü alfa (TNF-α) ve UTS2’ye maruz bırakıldı. İnkübasyon süresinin sonunda hücrelerden RNA izole edildi ve kantitatif ters transkripsiyon-polimeraz zincir reaksiyonu analizleri yapıldı. TNF-α maruziyeti, interlökin 6 ve nükleer faktör kappa B gen ekspresyon seviyelerinde anlamlı düzeyde bir artışa neden olmuştur. UTS2 maruziyeti, kendi gen ekspresyon seviyesini azaltmıştır. TNF-a ve UTS2 maruziyetleri, Kaspaz-3 gen ekspresyonu üzerinde istatistiksel olarak anlamlı bir farklılığa neden olmamıştır. Çalışmamızda, bulgularımız; insan osteoblast hücrelerinde UTS2’nin eksprese edildiğini ve UTS2’nin hücre kültür ortamına eklenmesi bu genin kendi ekspresyon seviyeleri üzerinde etkili olabileceğini göstermektedir.